| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |